{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:11:13Z","timestamp":1785247873446,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jtct.2021.02.025","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T07:38:15Z","timestamp":1614325095000},"page":"500.e1-500.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections"],"prefix":"10.1016","volume":"27","author":[{"given":"James","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushang D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caralyn","family":"Reyenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Balls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jtct.2021.02.025_bib0001","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbmt.2018.01.016","article-title":"Prognostic factors for mortality among day 1100 survivors after allogeneic hematopoietic cell transplantation","volume":"24","author":"Patel","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2021.02.025_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ofid\/ofy255","article-title":"Febrile neutropenia and long-term risk of infection among patients treated with chemotherapy for malignant diseases","volume":"5","author":"Nordvig","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jtct.2021.02.025_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.idc.2019.02.001","article-title":"Host and graft factors impacting infection risk in hematopoietic cell transplantation","volume":"33","author":"Kao","year":"2019","journal-title":"Infect Dis Clin N Am"},{"issue":"4","key":"10.1016\/j.jtct.2021.02.025_bib0004","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jtct.2021.02.025_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.idc.2019.02.006","article-title":"Fungal infections of the stem cell transplant recipient and hematologic malignancy patients","volume":"33","author":"Bays","year":"2019","journal-title":"Infect Dis Clin N Am"},{"key":"10.1016\/j.jtct.2021.02.025_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3410\/M3-14","article-title":"Emerging fungal infections in immunocompromised patients","volume":"3","author":"Low","year":"2011","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.jtct.2021.02.025_bib0007","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2016-10-748426","article-title":"The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality","volume":"129","author":"Hill","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.02.025_bib0008","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2021.02.025_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jbiotec.2016.12.022","article-title":"Application of next generation sequencing in clinical microbiology and infection prevention","volume":"243","author":"Deurenberg","year":"2017","journal-title":"J Biotechnol"},{"key":"10.1016\/j.jtct.2021.02.025_bib0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamaoncol.2019.4120","article-title":"Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer","volume":"6","author":"Goggin","year":"2019","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2021.02.025_bib0011","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ofid\/ofz327","article-title":"Non-invasive diagnosis of infection using plasma next-generation sequencing: a single center experience","volume":"6","author":"Rossoff","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jtct.2021.02.025_bib0012","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jtct.2021.02.025_bib0013","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: Sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease","volume":"92","author":"Hong","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.jtct.2021.02.025_bib0014","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ofid\/ofy301","article-title":"Plasma cell-free DNA next-generation sequencing to diagnose and monitor infections in allogeneic hematopoietic stem cell transplant patients","volume":"5","author":"Fung","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jtct.2021.02.025_bib0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. adults","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.02.025_bib0016","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/cc12896","article-title":"Characteristics and outcomes of culture-negative versus culture-positive severe sepsis","volume":"17","author":"Phua","year":"2013","journal-title":"Crit Care"},{"issue":"Suppl 1","key":"10.1016\/j.jtct.2021.02.025_bib0017","doi-asserted-by":"crossref","first-page":"S680","DOI":"10.1093\/ofid\/ofy210.1947","volume":"5","author":"Benamu","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jtct.2021.02.025_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa035","article-title":"Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study [e-pub ahead of print January 14, 2020]","author":"Hogan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2021.02.025_bib0019","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.12688\/f1000research.19766.3","article-title":"Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts","volume":"8","author":"Camargo","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.jtct.2021.02.025_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13071-015-0902-6","article-title":"Diagnosis of toxoplasmosis and typing of Toxoplasma gondii","volume":"8","author":"Liu","year":"2015","journal-title":"Parasit Vectors"},{"issue":"3","key":"10.1016\/j.jtct.2021.02.025_bib0021","doi-asserted-by":"crossref","first-page":"S365","DOI":"10.1016\/j.bbmt.2018.12.592","article-title":"Retrospective case-control study of the performance of cell-free plasma sequencing to detect invasive mold infections in hematopoietic cell transplant recipients with pneumonia","volume":"25","author":"Hill","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721007120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721007120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T02:18:57Z","timestamp":1725329937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721007120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2666636721007120"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.02.025","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with Suspected Infections","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}